Loading…
Regulation of Immune Activation by Optical Control of TLR1/2 Heterodimerization
The activation of toll‐like receptors (TLRs) plays important roles in the immune response. The ability to control the activities of TLRs could be usable as a switch for immune response. Here we have rationally designed and synthesized a photoswitchable Pam3CSK4 derivative—P10—to control the activati...
Saved in:
Published in: | Chembiochem : a European journal of chemical biology 2020-04, Vol.21 (8), p.1150-1154 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The activation of toll‐like receptors (TLRs) plays important roles in the immune response. The ability to control the activities of TLRs could be usable as a switch for immune response. Here we have rationally designed and synthesized a photoswitchable Pam3CSK4 derivative—P10—to control the activation of TLR1/2. The ground‐state trans‐P10 was able to stimulate and activate antigen‐presenting cells (APCs) by promoting TLR1/2 heterodimerization. However, cis‐P10, derived from UV irradiation of trans‐P10, reduced the activities of APCs by impeding the TLR1/2 heterodimerization. In the absence of UV radiation, the cis‐P10 slowly returned to its ground trans state, restoring the activities of the APCs stimulation. Our results indicated that optical control of TLR1/2 heterodimerization mediated by the photoswitchable P10 offers the potential to regulate immune activation and inflammation.
Reduction of systemic inflammation without immune system inhibition: A photoswitchable ligand for regulation of immune activation through optical control of the heterodimerization of toll‐like receptors 1 and 2 (TLR1/2) has been developed, offering the potential to regulate immune activation and inflammation. |
---|---|
ISSN: | 1439-4227 1439-7633 |
DOI: | 10.1002/cbic.201900591 |